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Abstract
We investigated the association between myeloperoxidase gene -463G > A polymorphism and premature coronary
artery disease (CAD) in two Chinese population samples: 229 patients and 230 controls. Genotypes were deter-
mined by ligase detection reaction-polymerase chain reaction sequencing and the grouping technique. We found
lower frequencies of both the A/A genotype and the A allele in patients (p < 0.05). Multivariate logistic regression
showed that the risk of premature CAD in subjects carrying the AA genotype was reduced by 83% in relation to indi-
viduals carrying the G/G genotype (OR = 0.172, 95% CI: 0.057-0.526, p = 0.002). Our results indicate that -463G > A
polymorphism of the myeloperoxidase gene is associated with premature CAD in Chinese individuals, suggesting
that the AA genotype is a protective factor against premature CAD.
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Myeloperoxidase(MPO)isaperoxidaseenzymepro-
ducedbywhitebloodcells(mainlyneutrophilgranulocytes
and mononuclear cells). It represents a class of heme-
proteins belonging to the heme peroxidase family. Several
single nucleotide polymorphisms (SNPs) are present at sp1
binding sites in the promoter region of the MPO gene, in-
cluding variants -463G/A, -129G/A, -V53F, -A332V,
-638C/A, I642L, and IVS11-2A/C. To date, several studies
have shown that the -463G/A, -129G/A, -V53F, -A332V,
and-638C/ASNPsandMPOlevelsareriskfactorsincoro-
nary artery disease (CAD) (Nikpoor et al., 2001; Brennan
et al., 2003; Chevrier et al., 2003, 2006; Rutgers et al.,
2003; Nicholls and Hazen, 2005; Stefanescu et al., 2008).
Although MPO gene -463G > A polymorphism was first
proven to be associated with CAD in a study by Nikpoor et
al., (2001), the inclusion criteria used were disputable,
since coronary stenosis of  30% qualified this as being a
CAD case. More importantly, genetic factors for CAD may
beeasiertodetectinyoungerthaninoldergroups,forinthe
latter many coexisting environmental factors might con-
tribute to the progress of CAD. Studies conducted with
younger CAD patients would thus help to reveal genetic
factorsrelevanttoCAD,ifexistent.Furthermore,todateno
reports have dealt with the association between MPO gene
-463G > A polymorphism and premature CAD. This was
the aim of the present study.
From October, 2005 to May, 2008, 459 patients
scheduled to undergo coronary angiography (CAG) for
chest discomfort or suspected CAD, were enrolled in this
study.229patients(menaged36-54yearsandwomenaged
39-64 years) with documented premature CAD (Kareinen
et al., 2001) constituted the case group. CAD was consid-
ered to be premature if occurring in men with less than 55
years of age and women with less than 65 years at the time
ofdiagnosis.PatientswithCADpresentedstenosis(50%)
in at least one main coronary artery or had undergone myo-
cardial infarction defined according to WHO criteria
(WHO, 1990). 230 age- and sex-matched patients without
detectable coronary stenosis in CAG were used as controls.
All patients presenting infectious diseases, valvular and
congenitalheartdisease,theXsyndrome,connectivetissue
disease,rheumatism,malignanttumor,trauma,severeliver
or kidney disease, or non-coronary artery thrombotic dis-
ease, or who were making use of anti-inflammatory drugs,
were excluded from the study.
Anthropometric measurements and blood pressure
determinationwereperformedaccordingtostandardproto-
cols. Body mass index (BMI) was calculated as the weight
in kilograms divided by the square of the height in meters.
Information on smoking habits and family history was ob-
tained from all sampled individuals. The study protocol
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Venous blood was drawn from fasting subjects with
0.1%EDTA.Onesamplefromeachsubjectwasusedtoan-
alyze fasting blood sugar content (FBS), total cholesterol
(TC), triglycerides (TG), LDL-cholesterol, HDL-choles-
terol (HDL-C), apolipoprotein A1 (apoA1), apolipoprotein
B (apoB) and lipoprotein a [Lp(a)]. A further sample was
centrifuged (3,000 rpm for 15 min), the blood cells then be-
ing separated and stored in micro-tubes -70 °C for genomic
DNA extraction. Plasma concentrations of TC, TG, HDL-
C, and LDL-C were determined by standard biochemical
methods through using a chemistry analyzer (Beckman
Coulter SYNCHRON LX20 Clinical System, Fullerton,
CA, USA).
DNA was obtained from blood cells by means of a
whole-bloodgenomeDNAextractionreagentkit[Axygene
Biotechnology (Hangzhou) Limited (Hangzhou City, Chi-
na)], according to manufacturer’s instructions.
Genotyping was performed through ligase detection
reaction (LDR) (Favis et al., 2000; Xiao et al., 2006) and
polymerase-chain reaction (PCR) sequencing-type tech-
nology. Primer sequence included the use of upstream
(5’-CGG TAT AGG CAC ACA ATG GTG AG-3’) and
downstream (5’-GCA ATG GTT CAA GCG ATT CTT
C-3’) primers. The PCR product was a 350 bp fragment in-
cluding -463G > A SNP. Probe sequences used were P-G
AAGAATCGCTTGAACCATTGCACATTTTTTTTTTT
TTTTT – FAM, TTTTTTTTTTTTTTTCCCAGCTACTC
GGGAGGCTCAGGCG,TTTTTTTTTTTTTTTTTTTCC
CAGCTACTCGGGAGGCTCAGGCA for rs2333227
SNP modified, rs2333227_C and rs2333227_T, respec-
tively. A Tris-EDTA loading buffer was prepared accord-
ing to the molecular weight of the respective primer and
fluorescent probe, and diluted to 50 pmol/L as the stock
solution. Thermal cycling of the PCR process was per-
formed under the following conditions: 70 °C for 15 min,
followed by 35 cycles of 94 °C for 30 s, 60 °C for 90 s,
72 °C for 1 min and a final extension of 72 °C for 10 min.
PCR products were visualized after electrophoresis on 3%
agarose gel. LDR was carried out under the following con-
ditions: 95 °C for 2 min, followed by 35 cycles of 94 °C for
30 s and 60 °C for 2 min. The sequence was detected and
genotypes were obtained through a sequencing system
(ABI377, Application Biotechnology Corporation).
Statistical analyses were undertaken using SPSS 12.0
software and included descriptive statistics, Student’s
t-tests, comparisons of gene and genotype frequencies be-
tweenthetwogroups,regressionandmultivariateanalyses,
and the calculation of odd-ratios with corresponding 95%
confidence intervals.
The analysis of baseline characteristics, lipids, and
glucose levels in patients with premature CAD and in the
controlgroupisshowninTable1.Theprevalenceofsmok-
ing(44.1%vs.23.5%),hypertension(64.2%vs.51.7%),di-
abetes (22.3% vs. 11.7%), and a family history of CAD
(36.7% vs. 21.7%), were significantly higher among pa-
tients than in the control group. The levels of FBS, TC, TG,
LDL-C, apoB, and Lp(a) in the case group were signifi-
cantlyhigherthanthoseinthecontrolgroup.Nosignificant
differences were detected in the levels of HDL-C and
apoA1, as well as in preference by sex, average age and
body mass indexes between cases and controls.
The polymorphism frequency distribution between
the case and control groups is shown in Table 2. The GG
genotype was found to be the most frequent genotype in
both cases (66.4%) and controls (58.7%). Frequencies of
the AA genotype and the A allele were significantly lower
among patients than controls.
With respect to relationship between risk factors,
MPO gene -463G > A polymorphism and premature CAD
(Table3),nosignificantdifferencesweredetectedforBMI,
FBS, all lipid parameters, hypertension, smoking, diabetes
and a family history of CAD, when the genotypes of cases
and controls were compared. Among all the covariates ex-
amined as potential confounders, only TC, diabetes mel-
litus, smoking and a family history of CAD contributed to
the final multivariate model. The other variables, including
BMI, FBS, TG, apolipoproteins, and hypertension, were
not identified as independent variables. Adjusting to these
covariates unmasked a significant association between
MPO gene -463G > A genotypes and premature CAD. In
patients carrying the AA genotype, the risk of premature
CAD was reduced by 83% in relation to that of individuals
carrying the G/G genotype (OR = 0.172, 95% CI:
0.057~0.526, p = 0.002).
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Table 1 - Comparison of baseline characteristics between CAD case and
control groups (meanSD)
Controls (n = 230) Cases (n = 229)
Age (ys) 52.90  7.42 52.33  6.97
Sex, male (%) 125 (54.3) 131 (57.2)
BMI (kg/m
2) 24.56  3.27 25.10  2.90
FBS (mmol/L) 5.56  1.38 6.07  2.12
*
TC (mmol/L) 4.24  0.98 4.74  1.06
*
TG (mmol/L) 1.97 [0.66, 7.14] 2.18 [0.72, 6.64]
*
HDL-C (mmol/L) 1.15  0.27 1.13  0.28
LDL-C (mmol/L) 2.57  0.73 2.88  0.72
*
apoA1 (mmol/L) 1.26  0.22 1.21  0.28
apoB (mmol/L) 0.82  0.30 0.94  0.28
*
Lp(a) (mg/L) 153.80  220.69 266.39  303.51
*
Values are expressed as meanSD; *, p < 0.01 (cases compared to con-
trols). BMI, body mass index; CAD, coronary artery disease; FBS, fasting
blood sugar; HDL-C, high-density lipoprotein-cholesterol; TC, total cho-
lesterol; TG, triglyceride; LDL-C, low-density lipoprotein-cholesterol;
apoA, apolipoprotein A; apoB, apolipoprotein B; Lp(a), lipoprotein (a).We detected a significantly decreased risk of prema-
ture CAD in those individuals among native Chinese bear-
ing the MPO gene -463 AA genotype. The MPO gene is
located in chromosome 17q23-q24, and its expression is
regulated by nutrilites (Denzler et al., 1997). The MPO
-463G > A polymorphism, located at the promoter region,
wasfirstdetectedbyAustinetal.(1993)inastudyonacute
myeloid leukemia patients. More recently, this same gene
polymorphism was proven to be a risk of both CAD
(Nikpoor et al., 2001) and cardiovascular events in CAD
patients, the A allele being associated with less probability
of developing cardiovascular disease (Asselbergs et al,
2004). The patients used in these studies were significantly
older and the angiography criteria for CAD cases were dis-
putable due to coronary stenosis of  30% being qualified
as a CAD case (Nikpoor et al., 2001). Since genetic factors
for CAD may be easier to detect in younger groups than in
older ones, we assumed that this gene could be closely re-
lated with premature CAD. Indeed, by using groups of
younger subjects in our case-control study, we found that
the risk of premature CAD was significantly reduced in
Chinese patients with the AA genotype, in accordance with
theresultsobtainedforCADbyNikpooretal.(2001)when
using older subjects.
It has been reported that MPO gene -463G > A poly-
morphism is related to changes in lipid levels (Nikpoor et
al., 2001), and is a mechanism that may be involved in the
oxidation of low-density lipoprotein, the high levels of
MPO increasing the brittleness of artery plaques, thereby
converting the plaque from the stable to the unstable state,
thus increasing the risk of acute coronary syndrome
(Sugiyama et al., 2001; Ndrepepa et al., 2008). The MPO
-463Aallelecouldinterferewiththebindingsitesofthesp1
transcription factor, by reducing the level of MPO gene ex-
pressioninitsroleinatheroscleroticplaqueformation,thus
having a definite impact on the risk of CAD. Meanwhile,
MPO could promote the oxidation of HDL-C and affect the
reverse transport role of cholesterol, thereby interfering in
the development of atherosclerosis. The multivariate logis-
tic regression that we performed showed that TC, diabetes
mellitus, smoking and a family history of CAD are inde-
pendentpredictorsofprematureCAD,thusconfirmingthat
these are really traditional cardiovascular risk factors con-
tributing independently to this disease (Schaefer et al.,
1994; Bostom et al., 1996).
Ourstudyandtheresultsthencenaturallypresentcer-
tain limitations, since the study-group was obtained from a
single hospital in Southeast China, and the samples might
not include all the characteristics of patients from other
centers. It is also generally accepted that CAD is a disease
produced by both multiple genes and environmental fac-
tors,andmanyothergenescouldbepotentialcandidatesfor
this sickness. Furthermore, since the MPO AA genotype is
relativelyinfrequent,theactualvalueofgenotypedetection
in the primary prevention of CAD may be disputable.
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